SREBF1 and congestive heart failure: Additionally, the improved plasma lipid profiles in the LC-CHF group, including lower LDL-C + VLDL-C and total cholesterol levels, align with the known lipid-modulating effects of omega-3 fatty acids in fish oil, which activate PPARα and suppress SREBP1c activity, directly influencing lipid metabolism [30,31].